Systemic hypotension following intravenous administration of contrast medium during computed tomography.

Trial Profile

Systemic hypotension following intravenous administration of contrast medium during computed tomography.

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Oct 2015

At a glance

  • Drugs Iodixanol (Primary) ; Iopromide
  • Indications Hepatic tumours
  • Focus Adverse reactions
  • Most Recent Events

    • 24 Oct 2015 Status changed from recruiting to completed as per European Clinical Trials Database record.
    • 12 Nov 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top